Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature (Q92204688)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

review article

0 references

title

Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Mohammad Abufaraj

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

Shahrokh Shariat

series ordinal

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

6

Morgan Rouprêt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

5

Pierre I Karakiewicz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

8

Seth P Lerner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

10

Francesco Soria

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

1

Beat Foerster

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

7

Paolo Gontero

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

author name string

Stephan Broenimann

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

publication date

4 March 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

page(s)

430-436

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

cites work

Cancer statistics, 2018.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Conditional survival after radical nephroureterectomy for upper tract carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Risk-adapted strategy for the kidney-sparing management of upper tract tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Serial retrograde instillations of sustained release formulation of mitomycin C to the upper urinary tract of the Yorkshire swine using a thermosensitive polymer: Safety and feasibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Drug-eluting biodegradable ureteral stent: New approach for urothelial tumors of upper urinary tract cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Metaprop: a Stata command to perform meta-analysis of binomial data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Meta-analysis in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

The management of transitional cell carcinoma in solitary renal units

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Adjuvant mitomycin C following endoscopic treatment of upper tract transitional cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

13-year experience with percutaneous management of upper tract transitional cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Percutaneous management of renal pelvic urothelial tumors: long-term followup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Setting a new standard for topical therapy of upper-tract transitional-cell carcinoma: BCG and interferon-alpha2B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Bacillus Calmette-Guérin instillation treatment for carcinoma in situ of the upper urinary tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Intrarenal bacillus Calmette-Guérin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Intravesical instillation of bacille Calmette-Guérin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Clinical outcome of bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Guérin therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Outcomes of intrarenal Bacillus Calmette-Guérin/interferon-α2B for biopsy-proven upper-tract carcinoma in situ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Efficacy and Tolerability of Bacillus Calmette-Guérin Therapy as the First-Line Therapy for Upper Urinary Tract Carcinoma In Situ.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Assessment of vesicoureteral reflux in patients with self-retaining ureteral stents: implications for upper urinary tract instillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Which is best method for instillation of topical therapy to the upper urinary tract? An in vivo porcine study to evaluate three delivery methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Comparison of 3 upper tract anticarcinogenic agent delivery techniques in an ex vivo porcine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2019.02.004

10.1016/J.UROLONC.2019.02.004

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30846387%20AND%20SRC:MED&resulttype=core&format=json

27 April 2020

1 reference